Toggle Offcanvas
...
 
Telmisartan Tenders

Telmisartan Tenders

View Telmisartan tenders, RFPs and contracts. Bid on readily available Telmisartan tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Telmisartan tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Telmisartan.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Telmisartan market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Telmisartan tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

397 Live Notices for Telmisartan Tenders

Showing 1 to 20

55. Generika Advertisement_Fl
country Germany
posting date15 Mar 2025
deadline24 Mar 2025
55. Generika Advertisement_Fl
country Germany
posting date15 Mar 2025
deadline24 Mar 2025
6505--760-25-1-050-0237 -Leavenworth Cmop Om Pharmaceuticals -(Va-25-00028391)
country United States
posting date07 Mar 2025
deadline21 Mar 2025
6505--760-25-1-050-0237 -Leavenworth Cmop Om Pharmaceuticals -(Va-25-00028391)
country United States
posting date07 Mar 2025
deadline21 Mar 2025
Botulinic Toxin Type 100Ui, Sulfassalazine 500Mg And Others - Ugps - Mj
country Brazil
posting date07 Mar 2025
deadline24 Mar 2025
Botulinic Toxin Type 100Ui, Sulfassalazine 500Mg And Others - Ugps - Mj
country Brazil
posting date07 Mar 2025
deadline24 Mar 2025
Trospio 30 Mg Cmcm Rec 1000020799
country Chile
posting date19 Feb 2025
deadline20 Mar 2025
Trospio 30 Mg Cmcm Rec 1000020799
country Chile
posting date19 Feb 2025
deadline20 Mar 2025
55Th Generics Tender_Fl
country Germany
posting date12 Feb 2025
deadline17 Mar 2025
55Th Generics Tender_Fl
country Germany
posting date12 Feb 2025
deadline17 Mar 2025
55Th Generics Tender_Fl
country Germany
posting date05 Feb 2025
deadline17 Mar 2025
55Th Generics Tender_Fl
country Germany
posting date05 Feb 2025
deadline17 Mar 2025
Pharmaceutical Discount Agreements From April 1, 2025 For Various Active Ingredients Within The Framework Of An Open-House Procedure
country Germany
posting date03 Feb 2025
deadline01 Feb 2027
Pharmaceutical Discount Agreements From April 1, 2025 For Various Active Ingredients Within The Framework Of An Open-House Procedure
country Germany
posting date03 Feb 2025
deadline01 Feb 2027
Pharmaceutical Discount Agreements From April 1, 2025 For Various Active Ingredients Within The Framework Of An Open-House Procedure
country Germany
posting date03 Feb 2025
deadline01 Feb 2027
Pharmaceutical Discount Agreements From April 1, 2025 For Various Active Ingredients Within The Framework Of An Open-House Procedure
country Germany
posting date03 Feb 2025
deadline01 Feb 2027
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb) V For The Active Ingredient Telmisartan + Amlodipine, (Obg) Atc C09Db04 For The Period 01.03.2025 - 28.02.2027
country Germany
posting date17 Jan 2025
deadline05 Jan 2027
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb) V For The Active Ingredient Telmisartan + Amlodipine, (Obg) Atc C09Db04 For The Period 01.03.2025 - 28.02.2027
country Germany
posting date17 Jan 2025
deadline05 Jan 2027
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb) V For The Active Ingredient Telmisartan + Amlodipine, (Obg) Atc C09Db04 For The Period 01.03.2025 - 28.02.2027
country Germany
posting date16 Jan 2025
deadline05 Jan 2027
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb) V For The Active Ingredient Telmisartan + Amlodipine, (Obg) Atc C09Db04 For The Period 01.03.2025 - 28.02.2027
country Germany
posting date16 Jan 2025
deadline05 Jan 2027

Share Share this page